FacebookTwitterLinkedInGoogle+RSS Feed
Fire EMSEMS TodayEMS Insider

Drug Therapy Doesn't Buy Time in Heart Attack

BOSTON -- Drugs given to buy time for heart attack patients who do not have quick access to angioplasty do not help them live any longer or prevent further heart problems, researchers reported on Wednesday.

The international study of thousands of patients is bad news for people who do not live near a hospital equipped to reopen blocked arteries or who come to a hospital where there is no staff available to do the procedure, the researchers report in the New England Journal of Medicine.

To read more about this, click here.


Cardiac Arrest Registry to Enhance Survival to Begin Collecting Data to Measure CPR Quality

Data will assist in providing uniform reporting metrics back to agencies to assist with their internal quality improvement efforts.

Epileptic Effect: The Aftermath of a Seizure isn’t Always What it Seems

You and your partner are dispatched to a 60ish-year-old female with signs and symptoms of a possible stroke.

Thorough Assessment is Crucial in Patients with Respiratory Distress

Accurate observation and treatment go a long way when considering all causes of respiratory distress.

Oklahoma City & Tulsa EMS Become First System to Adopt ResQCPR as a Standard of Care

Today the Medical Control Board for the EMS System for Metropolitan Oklahoma City and Tulsa, Okla., unanimously voted to approve the ResQCPR system by ZOLL a...

Tilt Angle Significantly Affects CPR

Test on pigs show patient tilt angle can have a positive effect on cerebral perfusion.

ZOLL ResQCPR™ System Receives Premarket Approval from the FDA

Chelmsford, Mass.— ZOLL® Medical Corporation, a manufacturer of medical devices and related software solutions, today announced that the company&rs...

Features by Topic

Featured Careers




Learn about new products and innovations featured at EMS Today 2015


JEMS Connect




Blogger Browser

Today's Featured Posts